Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Non-Current Deferred Revenue (2014 - 2016)

Updated

Aytu Biopharma (AYTU) posted Non-Current Deffered Revenue of $361,607 for fiscal Q3 2016 (quarter ended Mar 31, 2016), down 5.6% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Non-Current Deferred Revenue (2014 - 2016) Analysis & Trends

At the end of FY2015 (ended Jun 30, 2015), Aytu Biopharma's Non-Current Deffered Revenue came in at $425,893, down 16.8% from FY2014.

  • In prior fiscal years, Aytu Biopharma's Non-Current Deffered Revenue was $511,607 in FY2014.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior fiscal quarters was $383,036 (Q2 2016), $404,465 (Q1 2016) and $425,893 (Q4 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 361,607.00
Dec 31, 2015 383,036.00
Sep 30, 2015 404,465.00
Jun 30, 2015 425,893.00
Mar 31, 2015 447,321.00
Jun 30, 2014 511,607.00
API Access

Aytu Biopharma Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEY